Fernanda Elı́as

439 total citations
21 papers, 361 citations indexed

About

Fernanda Elı́as is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Fernanda Elı́as has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Fernanda Elı́as's work include Immune Response and Inflammation (9 papers), Immunotherapy and Immune Responses (7 papers) and RNA Interference and Gene Delivery (6 papers). Fernanda Elı́as is often cited by papers focused on Immune Response and Inflammation (9 papers), Immunotherapy and Immune Responses (7 papers) and RNA Interference and Gene Delivery (6 papers). Fernanda Elı́as collaborates with scholars based in Argentina, United States and Germany. Fernanda Elı́as's co-authors include Juan Fló, Juan M. Corchado, Alejandro D. Montaner, Jorge Zorzópulos, Santiago Zelenay, Norma Alejandra Chasseing, Leonardo Lizárraga, Oscar E. Pérez, Karina D. Martínez and Carla Spagnuolo and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetologia.

In The Last Decade

Fernanda Elı́as

21 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Elı́as Argentina 11 139 102 60 43 38 21 361
Elizabeth A. Berger United States 14 150 1.1× 163 1.6× 22 0.4× 19 0.4× 24 0.6× 35 471
Young Bin Im South Korea 14 83 0.6× 243 2.4× 48 0.8× 43 1.0× 20 0.5× 29 551
Charis R. Saville United Kingdom 7 167 1.2× 103 1.0× 40 0.7× 34 0.8× 34 0.9× 7 428
Denise Schlorke Germany 8 144 1.0× 125 1.2× 31 0.5× 24 0.6× 22 0.6× 9 370
Ricarda Cortés-Vieyra Mexico 9 180 1.3× 158 1.5× 38 0.6× 34 0.8× 25 0.7× 10 419
David B. Sheedy United States 9 139 1.0× 66 0.6× 22 0.4× 35 0.8× 8 0.2× 18 469
Siân E. Owens United Kingdom 11 116 0.8× 149 1.5× 18 0.3× 23 0.5× 39 1.0× 17 396
Eric B. Nonnecke United States 10 92 0.7× 261 2.6× 67 1.1× 81 1.9× 64 1.7× 17 521
Junichi Sano Japan 12 60 0.4× 77 0.8× 29 0.5× 39 0.9× 53 1.4× 37 354
Claudette Fuchey France 12 42 0.3× 204 2.0× 78 1.3× 40 0.9× 31 0.8× 17 623

Countries citing papers authored by Fernanda Elı́as

Since Specialization
Citations

This map shows the geographic impact of Fernanda Elı́as's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Elı́as with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Elı́as more than expected).

Fields of papers citing papers by Fernanda Elı́as

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Elı́as. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Elı́as. The network helps show where Fernanda Elı́as may publish in the future.

Co-authorship network of co-authors of Fernanda Elı́as

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Elı́as. A scholar is included among the top collaborators of Fernanda Elı́as based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Elı́as. Fernanda Elı́as is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathieu, Patricia, et al.. (2023). Oligodeoxynucleotide IMT504: Effects on Central Nervous System Repair Following Demyelination. Molecular Neurobiology. 61(7). 4146–4165. 1 indexed citations
2.
Alaimo, Agustina, Fernanda Elı́as, Guadalupe García Liñares, et al.. (2020). Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: Impact on human ARPE-19 culture cells. International Journal of Biological Macromolecules. 165(Pt A). 804–821. 58 indexed citations
3.
Zorzópulos, Jorge, Steven M. Opal, Juan M. Corchado, et al.. (2017). Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. World Journal of Stem Cells. 9(3). 45–45. 9 indexed citations
4.
Corchado, Juan M., Andrea Ziblat, Fernanda Elı́as, et al.. (2015). PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56+ (NK and NKT) Cells. PLoS ONE. 10(2). e0117484–e0117484. 14 indexed citations
5.
Corchado, Juan M., Fernanda Elı́as, Juan Fló, et al.. (2014). Non-Clinical Safety Studies of IMT504, a Unique Non-CpG Oligonucleotide. Nucleic Acid Therapeutics. 24(4). 267–282. 10 indexed citations
6.
Montaner, Alejandro D., Juan M. Corchado, Juan Fló, et al.. (2012). IMT504: A New and Potent Adjuvant for Rabies Vaccines Permitting Significant Dose Sparing. 2(4). 182–188. 10 indexed citations
7.
9.
Corchado, Juan M., Fernanda Elı́as, Juan Fló, et al.. (2009). A High Dose of IMT504, the PyNTTTTGT Prototype Immunostimulatory Oligonucleotide, Does Not Alter Embryonic Development in Rats. Oligonucleotides. 20(1). 33–36. 9 indexed citations
10.
Coronel, Marı́a Florencia, Juan M. Corchado, Fernanda Elı́as, et al.. (2008). Oligonucleotide IMT504 reduces neuropathic pain after peripheral nerve injury. Neuroscience Letters. 444(1). 69–73. 19 indexed citations
11.
Elı́as, Fernanda, et al.. (2007). PyNTTTTGT Oligonucleotides as Tools in Tissue Repair Procedures. 2 indexed citations
12.
Corchado, Juan M., et al.. (2006). Immunostimulatory PyNTTTTGT Oligodeoxynucleotides: Structural Properties and Refinement of the Active Motif. Oligonucleotides. 16(3). 275–285. 11 indexed citations
13.
Corchado, Juan M., Fernanda Elı́as, Alejandro D. Montaner, et al.. (2006). Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.. PubMed. 66(1). 9–16. 10 indexed citations
14.
Montaner, Alejandro D., Fernanda Elı́as, Juan M. Corchado, et al.. (2005). Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route. Vaccine. 24(11). 1889–1896. 7 indexed citations
15.
Elı́as, Fernanda, Juan Fló, Juan M. Corchado, et al.. (2005). PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant Hepatitis B vaccine that enhances the Th1 response. Vaccine. 23(27). 3597–3603. 22 indexed citations
16.
Elı́as, Fernanda, et al.. (2003). Strong Cytosine-Guanosine-Independent Immunostimulation in Humans and Other Primates by Synthetic Oligodeoxynucleotides with PyNTTTTGT Motifs. The Journal of Immunology. 171(7). 3697–3704. 65 indexed citations
17.
Zelenay, Santiago, Fernanda Elı́as, & Juan Fló. (2003). Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. European Journal of Immunology. 33(5). 1382–1392. 34 indexed citations
18.
Elı́as, Fernanda & Juan Fló. (2002). Modulation of the immune response mediated by oral transgene administration of IL-10. Cellular Immunology. 216(1-2). 73–81. 4 indexed citations
20.
Fló, Juan, et al.. (1994). Impairment of B and T cell maturation in gut associated lymphoid tissues due to malnutrition during lactation. Developmental & Comparative Immunology. 18(6). 543–555. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026